The sequence [EKRKI(E/R)(K/L/R/S/T)] is a nuclear localization signal for importin 7 binding (NLS7).


Journal

Biochimica et biophysica acta. General subjects
ISSN: 1872-8006
Titre abrégé: Biochim Biophys Acta Gen Subj
Pays: Netherlands
ID NLM: 101731726

Informations de publication

Date de publication:
05 2021
Historique:
received: 08 07 2020
revised: 14 01 2021
accepted: 14 01 2021
pubmed: 23 1 2021
medline: 30 6 2021
entrez: 22 1 2021
Statut: ppublish

Résumé

Nuclear translocation of large proteins is mediated through specific protein carriers, collectively named karyopherins (importins, exportins and adaptor proteins). Cargo proteins are recognized by importins through specific motifs, known as nuclear localization signals (NLS). However, only the NLS recognized by importin α and transportin (M9 NLS) have been identified so far METHODS: An unsupervised in silico approach was used, followed by experimental validation. We identified the sequence EKRKI(E/R)(K/L/R/S/T) as an NLS signal for importin 7 recognition. This sequence was validated in the breast cancer cell line T47D, which expresses importin 7. Finally, we verified that importin 7-mediated nuclear protein transport is affected by cargo protein phosphorylation. The NLS sequence for importin 7 was identified and we propose this approach as an identification method of novel specific NLS sequences for β-karyopherin family members. Elucidating the complex relationships of the nuclear transporters and their cargo proteins may help in laying the foundation for the development of novel therapeutics, targeting specific importins, with an immediate translational impact.

Sections du résumé

BACKGROUND
Nuclear translocation of large proteins is mediated through specific protein carriers, collectively named karyopherins (importins, exportins and adaptor proteins). Cargo proteins are recognized by importins through specific motifs, known as nuclear localization signals (NLS). However, only the NLS recognized by importin α and transportin (M9 NLS) have been identified so far METHODS: An unsupervised in silico approach was used, followed by experimental validation.
RESULTS
We identified the sequence EKRKI(E/R)(K/L/R/S/T) as an NLS signal for importin 7 recognition. This sequence was validated in the breast cancer cell line T47D, which expresses importin 7. Finally, we verified that importin 7-mediated nuclear protein transport is affected by cargo protein phosphorylation.
CONCLUSIONS
The NLS sequence for importin 7 was identified and we propose this approach as an identification method of novel specific NLS sequences for β-karyopherin family members.
GENERAL SIGNIFICANCE
Elucidating the complex relationships of the nuclear transporters and their cargo proteins may help in laying the foundation for the development of novel therapeutics, targeting specific importins, with an immediate translational impact.

Identifiants

pubmed: 33482249
pii: S0304-4165(21)00010-6
doi: 10.1016/j.bbagen.2021.129851
pii:
doi:

Substances chimiques

IPO7 protein, human 0
Karyopherins 0
Nuclear Localization Signals 0
Receptors, Cytoplasmic and Nuclear 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

129851

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Athanasios A Panagiotopoulos (AA)

Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, 71013, Greece.

Chara Polioudaki (C)

Laboratory of Biochemistry, School of Medicine, University of Crete, 71013, Greece.

Sotirios G Ntallis (SG)

Laboratory of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.

Dimitris Dellis (D)

Greek Research & Technology Network, Athens 11523, Greece.

George Notas (G)

Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, 71013, Greece.

Christos A Panagiotidis (CA)

Laboratory of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.

Panayiotis A Theodoropoulos (PA)

Laboratory of Biochemistry, School of Medicine, University of Crete, 71013, Greece.

Elias Castanas (E)

Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, 71013, Greece. Electronic address: castanas@uoc.gr.

Marilena Kampa (M)

Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, 71013, Greece. Electronic address: kampam@uoc.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH